NF Trinity Capital’s Celgene Corp CELG Stock Holding History

NF Trinity Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-107,491	Closed	-$6.89M	–	49
2018 Q4	$6.89M	Hold	107,491	–	–	1.12%	24
2018 Q3	$9.62M	Hold	107,491	–	–	1.27%	22
2018 Q2	$8.54M	Hold	107,491	–	–	1.17%	21
2018 Q1	$9.59M	Hold	107,491	–	–	1.32%	18
2017 Q4	$11.2M	Buy	107,491 +36,574	+52%	+$4.13M	1.46%	16
2017 Q3	$10.3M	Hold	70,917	–	–	1.48%	16
2017 Q2	$9.21M	Hold	70,917	–	–	1.31%	18
2017 Q1	$8.82M	Sell	70,917 -31,000	-30%	-$3.71M	1.19%	19
2016 Q4	$11.8M	Sell	101,917 -70,000	-41%	-$7.8M	1.66%	16
2016 Q3	$18M	Buy	171,917 +200	+0.1%	+$21.6K	2%	14
2016 Q2	$16.9M	Buy	171,717 +25,000	+17%	+$2.59M	1.86%	17
2016 Q1	$14.7M	Buy	146,717 +121,717	+487%	+$12.5M	1.78%	17
2015 Q4	$2.99M	Buy	+25,000	New	+$2.89M	0.34%	39

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NF Trinity Capital's CELG Position: Q1 2019 in Review

NF Trinity Capital sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 107,491 shares — an estimated $6.89M sold.

NF Trinity Capital first reported a position in CELG in Q4 2015 and held it in 13 quarters. The position peaked at $18M in Q3 2016. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

NF Trinity Capital reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
NF Trinity Capital sold 107,491 Celgene Corp shares in Q1 2019, an estimated $6.89M.
NF Trinity Capital first reported a position in Celgene Corp in Q4 2015 and held it in 13 quarters.
NF Trinity Capital's Celgene Corp position peaked at $18M in Q3 2016.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on NF Trinity Capital's 13F filing for Q1 2019, filed 10 May 2019.